Abstract
The intercellular matrix is a highly organized, dynamic system that dictates the overall shape and structure of organs. The spatial and chemical signals which are present in the extracellular matrix modulate the phenotypic expression of epithelial and mesenchymal cells. In turn, these cells regulate the chemistry and structural organization of the extracellular matrix. This active interplay between cells and their products leads to the formation of a highly complex environment in which normal and neoplastic cells can thrive and proliferate. Proteoglycans are suitable candidates for mediating this constant exchange of information. For instance, they influence the diffusion of molecules across tissues, the migration of cells along defined pathways, the surface properties of cells, and the structure of biological filters. These effects are primarily mediated by the polyanionic nature of the proteoglycan, by their expanded configuration in tissues and body fluids, and by their ability to interact with a variety of important matrix macromolecules. They are indeed constituents of both the stromal matrix and the cell surface (Fig. 1), and their biosynthesis, secretion and metabolism are highly regulated by intrinsic and extrinsic signals. These molecules are composed of a protein backbone to which a number of glycosaminoglycan chains and oligosaccharides are covalently attached, much like the branches to a tree. The proteoglycan-rich intercellular matrix can thus be conceived as a microcosmic forest, the properties of which depend primarily on the number, size and structure of the various glycosaminoglycan chains and their complex intermolecular affiliations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bano M, Zwiebel JA, Salomon DS, Kidwell WR (1983) Detection and partial characterization of collagen synthesis stimulating activities in rat mammary adenocarcinomas. J Biol Chem 258: 2729–2735
Barsky SH, Rao CN, Grotendorst GR, Liotta LA (1982) Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol 108: 276–283
Barsky SH, Siegal GP, Jannotta F, Liotta LA (1983a) Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140–147
Barky SH, Togo S, Garbs S, Liotta LA (1983b) Type IV collagenase immunoreactivity in invasive breast carcinoma. Lancet 1: 296–297
Castor CW, Naylor B (1977) Acid mucopolysaccharide composition of serous effusions. Study of 100 patients with neoplastic and non-neoplastic conditions. Cancer 20: 462–466
Chiu B, Chug A, Tengblad A, Pearce R, McCaughey WTE (1984) Analysis of hyaluronic acid in the diagnosis of malignant mesothelioma. Cancer 54: 2195–2199
David G, Van Den Berghe H (1983) Transformed mouse mammary epithelial cells synthesize under-sulfated basement membrane proteoglycan. J Biol Chem 258: 7338–7344
Gallager JT, Hampson IN (1984) Proteoglycans in cellular differentiation and neoplasia. Biochem Soc Trans 12: 541–543
Graf M, Baici A, Sträuli P (1981) Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma. Lab Invest 45: 587–596
Hascall VC, Hascall GK (1981) Proteoglycans. In: Hay ED (ed) Cell biology of extracellular matrix. Plenum Press, New York, p 39
Heinegård DK, Paulsson M (1984) Structure and metabolism of proteoglycans. In: Piez DA, Reddi AH (eds) Extracellular biochemistry. Elsevier Publishing, New York, p 277
Hopwood JJ, Dorfman A (1978) Glycosaminoglycan synthesis by Wilms’ tumor. Pediat Res 12: 52–56
Hurst RE, Parmley RT, Nakamura N, West SS, Denys FR (1981) Heparan sulfate of AH-130 ascites hepatoma cells: a cell-surface glycosaminoglycan not displaced by heparin. J Histochem Cytochem 29: 731–737
Iozzo RV (1984 a) Proteoglycans and neoplastic-mesenchymal cell interactions. Hum Pathol 15: 2–10
Iozzo RV (1984 b) Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. J Cell Biol 99: 403–117
Iozzo RV (1985a) Proteoglycans: structure, function, and role in neoplasia. Lab Invest 53: 373–396
Iozzo RV (1985b) Neoplastic modulation of extracellular matrix. Colon carcinoma cells release polypeptides that alter proteoglycan metabolism in colon fibroblasts. J Biol Chem 260: 7464–7473
Iozzo RV, Muller-Glauser W (1985) Neoplastic modulation of extracellular matrix: proteoglycan changes in the rabbit mesentery induced by V2 carcinoma cells. Cancer Res 45: 5677–5687
Iozzo RV, Wight TN (1982) Isolation and characterization of proteoglycans synthesized by human colon and colon carcinoma. J Biol Chem 257: 11135–11144
Iozzo RV, Goldes JA, Chen W-J, Wight TN (1981) Glycosaminoglycans of pleural mesothelioma: a possible biochemical variant containing chondroitin sulfate. Cancer 48: 89–97
Iozzo RV, Bolender RP, Wight TN (1982) Proteoglycan changes in the intercellular matrix of human colon carcinoma. An integrated biochemical and stereologic analysis. Lab Invest 47: 124–138
Iozzo RV, Ketterer CL, Slaymaker DJ (1986) Evidence of a small hydrophobic domain in the core protein of heparan sulfate proteoglycan from human colon carcinoma cells. FEBS Lett 206: 304–308
Isemura M, Munakata H, Ototani N, Goto K, Yosizawa Z (1982) Glycosaminoglycans of rat colorectal adenocarcinoma. Gann 73: 721–727
Kawai T, Suzuki M, Shinmei M, Maenaka Y, Kageyama K (1985) Glycosaminoglycans in malignant diffuse mesothelioma. Cancer 56: 567–574
Kefalides NA, Alper R, Clark CC (1979) Biochemistry and metabolism of basement membranes. Int Rev Cytol 61: 167–228
Keller KL, Keller JM, Moy JN (1980) Heparan sulfates from Swiss mouse 3T3 and SV3T3 Cells: 0-sulfate difference. Biochemistry 19: 2529–2536
Khoory MS, Nesheim ME, Bowie EJW, Mann KG (1980) Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder. J Clin Invest 65: 666–674
Knudson W, Biswas C, Toole BP (1984) Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci USA 81: 6767–6771
Kramer RH, Vogel KG (1984) Selective degradation of basement membrane macromolecules by metastatic melanoma cells. J Natl Cancer Inst 72: 889–897
Kramer RH, Vogel KG, Nicolson GL (1982) Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. J Biol Chem 257: 2678–2686
Lewko WM, Liotta LA, Wicha MS, Vonderhaar BK, Kidwell WR (1981) Sensitivity of N-nitroso- methylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production. Cancer Res 41: 2855–2862
Lindahl U, Feingold DS, Rodén L (1986) Biosynthesis of heparin. Trends Biochem Sci 11: 221–225
Liotta LA, Abe S, Gehron-Robey P, Martin GR (1979) Preferential digestion of basement membrane collagen by an enzyme derived from metastatic murine tumor. Proc Natl Acad Sci USA 76: 2268–2272
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagens. Nature 284: 67–68
Liotta LA, Thorgeirsson UP, Garbisa S (1982) Role of collagenases in tumor cell invasion. Cancer Metastasis Rev 1: 277–288
Liotta LA, Rao CN, Barsky SH (1983) Tumor invasion and the extracellular matrix. Lab Invest 49: 636–649
Merrilees MJ, Finlay GJ (1985) Human tumor cells in culture stimulate glycosaminoglycan synthesis by human skin fibroblasts. Lab Invest 53: 30–36
Meyer K, Chaffee E (1939) Hyaluronic acid in pleural fluid associated with malignant tumor involving pleura and peritoneum. Proc Soc Exp Biol Med 42: 797–800
Morse BS, Nussbaum M (1967) The detection of hyaluronic acid in the serum and urine of a patient with nephroblastoma. Am J Med 42: 996–1002
Nakajima M, Irimura T, Di Ferrante DT, Di Ferrante N, Nicolson GL (1983) Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220: 611–613
Nakajima M, Irimura T, Di Ferrante N, Nicolson GL (1984) Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 259: 2283–2290
Nakamura N, Kojima J (1981) Changes in charge density of heparan sulfate isolated from cancerous human liver tissue. Cancer Res 41: 278–283
Nakamura N, Hurst RE, West SS (1978) Biochemical composition and heterogeneity of heparan sulfates isolated from AH-130 ascites hepatoma cells and fluid. Biochim Biophys Acta 538: 445–457
Nakano T, Fuji J, Tamura S, Amuro Y, Nabeshima K, Horai T, Hada T, Higashino K (1986) Glycosaminoglycans in malignant pleural mesothelioma. Cancer 57: 106–110
Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46: 2203–2207
Pal S, Strider W, Margolis R, Gallo G, Lee-Huang S, Rosenberg L (1978) Isolation and characterization of proteoglycans from human chondrosarcoma. J Biol Chem 253: 1279–1289
Palmer RN, Rick ME, Rick PD, Zeller J A, Gralnick HR (1984) Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med 310: 1696–1699
Poole AR, Tiltman KJ, Recklies AD, Stoker TAM (1978) Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 273: 545–547
Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283: 139–146
Powars DR, Allerton SE, Beierle J, Butler BB (1972) Wilms’ tumor. Clinical correlation with circulating mucin in three cases. Cancer 29: 1597–1605
Robinson J, Viti M, Hook M (1984) Structure and properties of an under-sulfated heparan sulfate proteoglycan synthesized by a rat hepatoma cell line. J Cell Biol 98: 946–953
Rosenberg L, Tang L-H, Pal S (1979) Biochemical assessment of malignancy in human chondrosarcoma. In: Gregory JD, Jeanloz RW Glycoconjugate research, vol I. Academic Press, New York, p 393
Russel JB, Steinherz PG, Miller Dr, Hilgartner MW (1984) A heparin-like anticoaglant in an 8-month-old boy with acute monoblastic leukemia. Am J Hematol 16: 83–90
Schürch W, Seemayer TA, Lagace R (1981) Stromal myofibroblasts in primary invasive and metastatic carcinomas. Virchows Arch (Pathol Anat) 391: 125–139
Seemayer TA, Schiirch W, Lagace R, Tremblay G (1979) Myofibroblasts in the stroma of invasive and meteastatic carcinoma. Am J Surg Pathol 3: 525–533
Sloane BF, Dunn JR, Honn KV (1981) Lysosomal cathepsin B: correlation with metastatic potential. Science 212: 1151–1153
Sugahara K, Schwartz NB, Dorfman A (1980) Defect in 3′-phosphoadenosine-5′-phosphosulfate formation in brachymorphic mice. Proc Natl Acad Sci USA 76: 6615–6619
Tarin D, Hoyt BJ, Evans DJ (1982) Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumors. Br J Cancer 46: 266–278
Thompson ME, Bromberg PA, Amenta JS (1969) Acid mucopolysaccharide determination: a useful adjunct for the diagnosis of malignant mesothelioma with effusions. Am J Clin Pathol 52: 335–339
Thonar EJ-MA, Sweet MBE, Immelman AR, Lyons G (1979) Structural study on proteoglycan from human chondrosarcoma. Arch Biochem Biophys 199: 179–189
Toole BP (1981) Glycosaminoglycans in morphogenesis. In: Hay ED (ed) Cell biology of extracellular matrix. Plenum Press, New York, p 259
Turpeeniemi-Hujanen T, Thorgeirsson UP, Hart IR, Grant SS, Liotta LA (1985) Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst 75: 99–103
Underhill CB, Keller JM (1975) A transformation-dependent difference in the heparan sulfate associated with the cell surface. Biochem Biophys Res Commun 63: 448–454
Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V (1983) Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 43: 2704–2711
Waxier B, Eisenstein R, Battifora H (1979) Electrophoresis of tissue glycosaminoglycans as an aid in the diagnosis of mesotheliomas. Cancer 44: 221–227
Wewer UM, Albrechtsen R, Rao CN, Liotta LA (1986) The extracellular matrix in malignancy. In: Kuhn K (ed) Rheumatology, vol 10. Karger, Basel, p 451
Winterbourne DJ, Mora PT (1981) Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation. J Biol Chem 256: 4310–4320
Woolley DE (1984) Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev 3: 361–372
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Iozzo, R.V. (1987). Proteoglycans and the Intercellular Tumor Matrix. In: Seifer, G. (eds) Morphological Tumor Markers. Current Topics in Pathology, vol 77. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71356-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-71356-9_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71358-3
Online ISBN: 978-3-642-71356-9
eBook Packages: Springer Book Archive